Literature DB >> 4833255

Taurine concentrations in congestive heart failure.

R Huxtable, R Bressler.   

Abstract

The concentration of taurine in the left ventricular muscle of hearts of patients who died of chronic congestive heart failure was twice that of patients who died of other causes and had no cardiac pathology. There was no corresponding difference in taurine concentrations in aortic tissue between the two groups. Stress-induced hypertension in rats also led to an increase in taurine concentration in the heart, whereas that in skeletal muscle and brain showed no significant alteration when compared to unstressed animals. Spontaneously hypertensive rats, of the Wistar-derived Okamato strain, showed a similar elevation in cardiac taurine compared to age-matched control Wistar rats.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4833255     DOI: 10.1126/science.184.4142.1187

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  12 in total

1.  Metabolomic analysis of serum and myocardium in compensated heart failure after myocardial infarction.

Authors:  M Dan McKirnan; Yasuhiro Ichikawa; Zheng Zhang; Alice E Zemljic-Harpf; Sili Fan; Dinesh Kumar Barupal; Hemal H Patel; H Kirk Hammond; David M Roth
Journal:  Life Sci       Date:  2019-02-05       Impact factor: 5.037

Review 2.  Ameliorative effects of taurine against diabetes: a review.

Authors:  Fengyuan Piao; Rana Muhammad Aadil; Raheel Suleman; Kaixin Li; Mengren Zhang; Pingan Wu; Muhammad Shahbaz; Zulfiqar Ahmed
Journal:  Amino Acids       Date:  2018-02-28       Impact factor: 3.520

3.  Non-targeted metabolomics analysis of cardiac Muscle Ring Finger-1 (MuRF1), MuRF2, and MuRF3 in vivo reveals novel and redundant metabolic changes.

Authors:  Ranjan Banerjee; Jun He; Carolyn Spaniel; Megan T Quintana; Zhongjing Wang; James Bain; Christopher B Newgard; Michael J Muehlbauer; Monte S Willis
Journal:  Metabolomics       Date:  2014-07-14       Impact factor: 4.290

4.  Potentiation by taurine of the inotropic effect of ouabain and the content of intracellular Ca++ and taurine in the heart.

Authors:  H I Iwata; S Fujimoto
Journal:  Experientia       Date:  1976-12-15

5.  Characterization of a carrier-mediated transport system for taurine in the fetal mouse heart in vitro.

Authors:  D S Grosso; W R Roeske; R Bressler
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

Review 6.  Taurine in infant nutrition.

Authors:  S Karan
Journal:  Indian J Pediatr       Date:  1991 May-Jun       Impact factor: 1.967

7.  Protective effect of taurine against isoprenaline-induced myocardial damage.

Authors:  H Ohta; J Azuma; S Onishi; N Awata; K Takihara; S Kishimoto
Journal:  Basic Res Cardiol       Date:  1986 Sep-Oct       Impact factor: 17.165

8.  The potential health benefits of taurine in cardiovascular disease.

Authors:  Yan-Jun Xu; Amarjit S Arneja; Paramjit S Tappia; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2008

Review 9.  The potential usefulness of taurine on diabetes mellitus and its complications.

Authors:  Takashi Ito; Stephen W Schaffer; Junichi Azuma
Journal:  Amino Acids       Date:  2011-03-25       Impact factor: 3.520

10.  Protective role of taurine against oxidative stress (Review).

Authors:  Stella Baliou; Maria Adamaki; Petros Ioannou; Aglaia Pappa; Mihalis I Panayiotidis; Demetrios A Spandidos; Ioannis Christodoulou; Anthony M Kyriakopoulos; Vassilis Zoumpourlis
Journal:  Mol Med Rep       Date:  2021-06-29       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.